Cellular Biomedicine (CBMG)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2009 | 12-2008 | 12-2007 | |
| Sales | 50 | 5 | 442 |
| Gross Profit | 50 | 5 | 442 |
| Operating Expenses | 797 | 1,227 | 999 |
| Operating Income | -747 | -1,222 | -557 |
| Interest Expense | 7 | 4 | 2 |
| Other Income | 1 | 21 | 27 |
| Pre-tax Income | -753 | -1,205 | -532 |
| Income Tax | N/A | N/A | 6 |
| Net Income Continuous | -753 | -1,205 | -540 |
| Net Income Discontinuous | N/A | -28 | N/A |
| Net Income | $-753 | $-1,233 | $-540 |
| EPS Basic Total Ops | -0.01 | -0.01 | 0.00 |
| EPS Basic Continuous Ops | -0.01 | -0.01 | 0.00 |
| EPS Diluted Total Ops | -0.01 | -0.01 | 0.00 |
| EPS Diluted Continuous Ops | -0.01 | -0.01 | 0.00 |
| EBITDA(a) | $-747 | $-1,222 | $-557 |